Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 14, 2016; 22(2): 842-852
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.842
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.842
Study | No. of patients | Stent | Indication | Mean age | Covering material | Patency duration between stent types | Complication |
Kang et al[6] | 26 | Not reported | Palliation/BTS | 58.0 | Fully/Partially (polyurethane) | No difference | More migration in fully covered stent group |
Choi et al[7] | 74 | Choo stent™ | Palliation | 60.0 | Fully/Partially (polyurethane) | No difference | More migration in covered stent group |
Lee et al[2] | 80 | Niti-S™ | Palliation/BTS | 63.3 | Partially (polyurethane) | No difference | More migration in covered stent group |
Park et al[3] | 151 | WallFlex™ | Palliation/BTS | 61.4 | Partially (polytetrafluoroethylene) | No difference | More tumor ingrowth in uncovered stent group/more migration in covered stent group |
Comvi™ | |||||||
Moon et al[4] | 68 | Niti-S™ D-type | Palliation/BTS | 65.8 | Partially (polytetrafluoroethylene) | No difference | More migration in covered stent group |
Comvi™ | |||||||
Park et al[8] | 103 | Wallstent™ | Palliation | 67.3 | Partially (polytetrafluoroethylene or silicon) | No difference | No difference between stent types/variable migration rates between manufacturers |
Niti-S™ | |||||||
Bonastent™ | |||||||
Hanarostent™ | |||||||
Choi et al[9] | 152 | Niti-S™ | Palliation/BTS | 70.0 | Not reported | No difference | More migration and perforation in covered stent group |
Hanarostent™ | |||||||
Choo stent™ | |||||||
Bonastent™ |
Name | Material | Diameter (mm) | Flare | Flare diameter (mm) | Length (mm) | Covered/uncovered | Feature | Manufacturer |
Colonic Z-stent™ | Stainless steel | 25 | A | 35 | 40, 60, 80, 100, 120 | Uncovered | No foreshortening | Cook |
Evolution™ | Nitinol | 25 | A | 30 | 60, 80, 100 | Uncovered | Controlled-release delivery system | Cook |
20 | A | 22 | 80, 100, 125, 150 | Partially covered | ||||
18, 20 | A | 23, 25 | 80, 100, 120 | Fully covered | ||||
Wallstent™ Endoprosthesis | Stainless steel | 20, 22 | NA | NA | 60, 90, 120 | Uncovered | Reconstrainable | Boston Scientific |
Wallstent™ Enteral | Elgiloy | 20, 22 | NA | NA | 60, 90 | Uncovered | Reconstrainable | Boston Scientific |
Wallflex™ Colonic | Nitinol | 22, 25 | A | 27, 30 | 60, 90, 120 | Uncovered | Reconstrainable | Boston Scientific |
Ultraflex™ colonic | Nitinol | 25 | A | 30 | 57, 87, 117 | Uncovered | Non-Reconstrainable | Boston Scientific |
Hanarostent™ colorectal | Nitinol | 22 | A | 28 | 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170 | Covered | Reconstrainable | MI tech |
24 | A | 30 | 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170 | Uncovered | ||||
Bonastent™ | Nitinol | 22, 24, 26 | NA | NA | 60, 80, 100, 120, 140, 160 | Covered | Non-foreshortening | EndoChoice |
Uncovered | ||||||||
Niti-S™ D-Enteral colonic stent | Nitinol | 18, 20, 22, 24 | NA | NA | 60, 80, 100, 120, 140, 150 | Uncovered | Reconstrainable | Taewoong medical |
Comvi™ Colonic stent | Nitinol | 18, 20, 22 | NA | NA | 60, 80, 100, 120 | Triple layered | Reconstrainable | Taewoong medical |
Niti-S™ S-enteral colonic stent | Nitinol | 18, 20 | A | 24 | 60, 80, 100, 120, 140, 150 | Covered | Reconstrainable | Taewoong medical |
BTS | Proximal colonic lesions | Palliative | Extra colonic obstruction | Benign lesions | Covered vs uncovered | |
ESGE | Δ | Δ | ○ | Δ | X | = |
ASGE | ○ | Δ | ○ | Δ | Δ | < |
KSGE | Δ | Δ | ○ | Δ | Δ | = |
- Citation: Kim EJ, Kim YJ. Stents for colorectal obstruction: Past, present, and future. World J Gastroenterol 2016; 22(2): 842-852
- URL: https://www.wjgnet.com/1007-9327/full/v22/i2/842.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i2.842